Merlin J, Crous A, Abrahamse H
Int J Mol Sci. 2024; 25(19).
PMID: 39409125
PMC: 11477455.
DOI: 10.3390/ijms251910796.
Niu R, Lan J, Liang D, Xiang L, Wu J, Zhang X
Cell Commun Signal. 2024; 22(1):474.
PMID: 39367435
PMC: 11451002.
DOI: 10.1186/s12964-024-01836-y.
Cigalotto L, Martinvalet D
Front Immunol. 2024; 15():1371743.
PMID: 38646541
PMC: 11026543.
DOI: 10.3389/fimmu.2024.1371743.
Miao R, Jiang C, Chang W, Zhang H, An J, Ho F
Immunity. 2023; 56(11):2523-2541.e8.
PMID: 37924812
PMC: 10872579.
DOI: 10.1016/j.immuni.2023.10.004.
Palamarchuk A, Kovalenko E, Streltsova M
Biomedicines. 2023; 11(4).
PMID: 37189709
PMC: 10136030.
DOI: 10.3390/biomedicines11041091.
Shuterin Enhances the Cytotoxicity of the Natural Killer Leukemia Cell Line KHYG-1 by Increasing the Expression Levels of Granzyme B and IFN-γ through the MAPK and Ras/Raf Signaling Pathways.
Lin J, Chuang Y, Chen M, Lo Y, Lin C, Ho H
Int J Mol Sci. 2022; 23(21).
PMID: 36361609
PMC: 9654641.
DOI: 10.3390/ijms232112816.
Impact of Machine Perfusion on the Immune Response After Liver Transplantation - A Primary Treatment or Just a Delivery Tool.
Panconesi R, Carvalho M, Dondossola D, Muiesan P, Dutkowski P, Schlegel A
Front Immunol. 2022; 13:855263.
PMID: 35874758
PMC: 9304705.
DOI: 10.3389/fimmu.2022.855263.
: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes.
McKenzie B, Khazen R, Valitutti S
Front Immunol. 2022; 13:894306.
PMID: 35592329
PMC: 9110820.
DOI: 10.3389/fimmu.2022.894306.
Cytolytic CD4 and CD8 Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease.
Bolivar-Wagers S, Larson J, Jin S, Blazar B
Front Immunol. 2022; 13:864748.
PMID: 35493508
PMC: 9040077.
DOI: 10.3389/fimmu.2022.864748.
Improved Purification of Human Granzyme A/B and Granulysin Using a Mammalian Expression System.
Rasi V, Hameed O, Matthey P, Bera S, Grandgenett D, Salentinig S
Front Immunol. 2022; 13:830290.
PMID: 35300343
PMC: 8921980.
DOI: 10.3389/fimmu.2022.830290.
Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?.
Vaka R, Deer E, LaMarca B
Antioxidants (Basel). 2022; 11(2).
PMID: 35204094
PMC: 8868187.
DOI: 10.3390/antiox11020210.
Toward a Better Classification System for NK-LGL Disorders.
Drillet G, Pastoret C, Moignet A, Lamy T, Marchand T
Front Oncol. 2022; 12:821382.
PMID: 35178350
PMC: 8843930.
DOI: 10.3389/fonc.2022.821382.
Granzymes: The Molecular Executors of Immune-Mediated Cytotoxicity.
Hay Z, Slansky J
Int J Mol Sci. 2022; 23(3).
PMID: 35163755
PMC: 8836949.
DOI: 10.3390/ijms23031833.
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
Deng M, Sun S, Zhao R, Guan R, Zhang Z, Li S
Mol Med. 2022; 28(1):16.
PMID: 35123387
PMC: 8818170.
DOI: 10.1186/s10020-022-00445-0.
Widespread discrepancy in genotypes and genetic backgrounds complicates granzyme A and other knockout mouse studies.
Rawle D, Le T, Dumenil T, Bishop C, Yan K, Nakayama E
Elife. 2022; 11.
PMID: 35119362
PMC: 8816380.
DOI: 10.7554/eLife.70207.
Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease.
Schneider A, Ozsoy M, Zimmermann F, Brunner S, Feichtinger R, Mayr J
Oxid Med Cell Longev. 2022; 2022:9151169.
PMID: 35035669
PMC: 8758306.
DOI: 10.1155/2022/9151169.
Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity?.
Bassoy E, Walch M, Martinvalet D
Front Immunol. 2021; 12:755856.
PMID: 34899706
PMC: 8653250.
DOI: 10.3389/fimmu.2021.755856.
Oxidative and Non-Oxidative Antimicrobial Activities of the Granzymes.
Lavergne M, Hernandez-Castaneda M, Mantel P, Martinvalet D, Walch M
Front Immunol. 2021; 12:750512.
PMID: 34707614
PMC: 8542974.
DOI: 10.3389/fimmu.2021.750512.
PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer.
Sun Y, Lu D, Yin Y, Song J, Liu Y, Hao W
Nat Commun. 2021; 12(1):5147.
PMID: 34446716
PMC: 8390757.
DOI: 10.1038/s41467-021-25417-6.
Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer.
Esteves A, Papaevangelou E, Dasgupta P, Galustian C
Front Oncol. 2021; 11:621550.
PMID: 33777767
PMC: 7988118.
DOI: 10.3389/fonc.2021.621550.